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Abstract
Background Splanchnic artery stenosis is common and
mostly asymptomatic and may lead to gastrointestinal
ischemia (chronic splanchnic syndrome, CSS). This study
was designed to assess risk factors for CSS in the medical
history of patients with splanchnic artery stenosis and
whether these risk factors can be used to identify patients
with high and low risk of CSS.
Methods All patients referred for suspected CSS under-
went a standardized workup, including a medical history
with questionnaire, duplex ultrasound, gastrointestinal
tonometry, and angiography. Deﬁnitive diagnosis and
treatment advice was made in a multidisciplinary team.
Patients with conﬁrmed CSS were compared with no-CSS
patients.
Results A total of 270 patients (102 M, 168 F; mean age,
53 years) with splanchnic artery stenosis were analyzed, of
whom 109 (40%) had CSS and 161 no CSS. CSS-patients
more often reported postprandial pain (87% vs. 72%,
p = 0.007), weight loss (85% vs. 70%, p = 0.006), adap-
ted eating pattern (90% vs. 79%, p = 0.005) and diarrhea
(35% vs. 22%, p = 0.023). If none of these risk factors
were present, the probability of CSS was 13%; if all were
present, the probability was 60%. Adapted eating pattern
(odds ratio (OR) 3.1; 95% conﬁdence interval (CI)
1.08–8.88) and diarrhea (OR 2.6; 95% CI 1.31–5.3) were
statistically signiﬁcant in multivariate analysis.
Conclusions In patients with splanchnic artery stenosis,
the clinical history is of limited value for detection of CSS.
A diagnostic test to detect ischemia is indispensable for
proper selection of patients with splanchnic artery stenosis
who might beneﬁt from treatment.
Introduction
The classical presentation of patients with chronic gastro-
intestinal ischemia, also called chronic splanchnic syn-
drome (CSS), consists of postprandial abdominal pain,
weight loss, and an abdominal bruit. However, it has been
shown that this classical triad is present in a minority [1–4].
In CSS, the postprandial pain typically starts 15–30 min
after the meal, may last for 2–3 hours, and may result in
fear of eating. The reduced caloric intake for fear of eating
causes the serious weight loss. Changes in bowel habits,
usually diarrhea, may sometimes occur [1, 4, 5]. Nausea,
dyspepsia with fullness, bloating, and pain after mental
stress or exercise also have been mentioned [6, 7]. Data on
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reporting on case series of 20 to 144 patients [1, 3]. To our
knowledge, no prospective studies of patients with
splanchnic artery stenosis comparing the clinical history in
those with and without ischemia have been published. Thus,
the precise role of clinical features in diagnosing CSS is
unknown.
The prevalence of asymptomatic splanchnic artery
stenosis increases up to 30–50% with age in elderly
subjects [8, 9]. In the majority of subjects these stenosis
remain asymptomatic (chronic splanchnic disease or
CSD), whereas in some CSS develops. Splanchnic artery
stenosis is caused by atherosclerosis in most cases. If
ischemic complaints have developed in presence of
extrinsic compression of the celiac artery by the arcuate
ligament of the diaphragm, celiac artery compression
syndrome (CACS) is diagnosed. Among young women,
this is the most prevalent cause of CSS [10]. Still, most
subjects with compression of the celiac artery remain
asymptomatic.
Weandothershavedemonstratedthatmeasurementofan
increased PCO2 in the gastric and small bowel lumen is
indicative of local ischemia [11, 12]. This local PCO2 stems
from buffering of protons produced during anaerobic
metabolisminthemucosaltissue,andispresentinallstudied
ischemia models [12]. The PCO2 can be measured with a
nasogastric balloon-tipped catheter attached to modiﬁed
capnograph, and allows for semicontinuous measurement.
An abnormal tonometry test after exercise or test meals
allowed for accurate selection of patients who may beneﬁt
treatment of vessels stenosis [3, 13].
Because the number of ‘‘incidentally found’’ splanchnic
artery stenosis will increase as a result of increased use of
high-resolution CT scan and MRI, the risk of overdiagnosis
and overtreatment is quite conceivable. It would therefore
be desirable to establish the sensitivity, speciﬁcity, and
positive and negative predictive value of the various
parameters in the medical history that may speciﬁcally
point to the presence or absence of clinical relevant
ischemia. That would allow for better identiﬁcation of
patients in whom diagnostic workup, such as tonometry,
and treatment would be indicated and in whom it could be
omitted. Our group, a nationwide referral center for
splanchnic vascular disorders, has ample experience with
analysis and treatment of this complex group of patients
[11, 14].
During the past decade, 40–50% of patients with
splanchnic artery stenosis who were referred where diag-
nosed with CSS [11, 15]. The purpose of this study was to
assess risk factors for CSS in the medical history of
patients with splanchnic artery stenoses and whether these
risk factors can be used to identify patients with high and
low risk of CSS.
Patients and methods
Patient selection and data collection
AllpatientsreferredforpossibleCSSundergoastandardized
diagnostic workup as previously reported [13]. All data are
recordedinadatabase.Forthisstudy,weincludeddataofall
patients referred between February 1, 2006 and May 31,
2009. Exclusion criteria were: 1) incomplete diagnostic
workup (no tonometry and no imaging or patients who were
not discussed in our Multi-Disciplinary Team (MDT) for
splanchnic ischemia; 2) previous treatment for CSS; 3)
nonobstructive mesenteric ischemia (NOMI), i.e., gastroin-
testinal ischemia in absence of splanchnic artery stenosis; 4)
alternative diagnosis found during evaluation; 5) follow-up
less than 3 months after treatment or patients lost to follow-
up after treatment.
Medical history and clinical features
All patients were asked to complete a questionnaire (see
Appendix). The questions were based on our initial studies
and relevant literature [3, 4, 6, 10, 11]. The medical history
notes of the two experienced main investigators (JKO and
RHG) also were analyzed to maximize the potential of
valuable factors. Both investigators have more than
20 years of experience in the ﬁeld of CSS. A clinical fea-
ture (e.g., weight loss) could be scored in both the ques-
tionnaire and medical history notes.
Duplex ultrasound
Duplex ultrasonography (DU) was performed after 6 hours
of fasting and using a standard protocol. The deﬁnition of
normal and stenotic artery origins was based on the criteria
published by Moneta et al. [15].
Tonometry
The principles of air tonometry have been described pre-
viously [2, 11]. Exercise tonometry was performed before,
during, and after 10 minutes of submaximal exercise. The
criteria as published by Otte et al. were used to deﬁne a
positive test result [11]. In the 24-hour tonometry, stan-
dardized meals were given to patients to provoke ischemia
[3]. The criteria published by Mensink et al. were used to
deﬁne a positive test result [16, 17].
Angiography
Digital subtraction angiography of the splanchnic arteries
was performed if the result of tonometry and/or duplex
ultrasound was abnormal. The origins of the splanchnic
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123vessels were visualized during expiration and inspiration as
described previously [3].
Diagnosis and follow-up
The results of the diagnostic workup were discussed in the
MDT consisting of a gastroenterologist, a vascular surgeon,
and an interventional radiologist and a consensus diagnosis
was made. The initial diagnosis was based on 1) clinical
presentation, 2) presence of splanchnic artery stenosis, and
3) results of tonometry. The diagnosis was classiﬁed as
CSS, CSD, or no CSD (alternative diagnosis). In this study,
the CSS group consisted of 1) CSS due to atherosclerotic
stenosis and 2) CSS due to eccentric celiac artery com-
pression by the arcuate ligament with ischemia (CACS).
Only patients with the diagnosis CSS were considered for
treatment.
The ﬁnal diagnosis was based on the outcome of follow-
up, including the effects of treatment. In treated patients,
the diagnosis was sustained if symptoms were severely
reduced or completely resolved after successful revascu-
larization of the affected vessels. If an alternative expla-
nation for the complaints was found, the diagnosis was
adjusted. The ﬁnal diagnosis was used for the analysis.
Treated patients were scheduled for follow-up. The ﬁrst
follow up appointment was 3 months after treatment, and
thereafter every 6 months during the ﬁrst 2 years for
assessment of the medical history and a duplex ultrasound
scan. Untreated patients were not seen on a regular basis in
our center but were further treated by the referring physi-
cian. From a previous study, it was learned that this is a
safe strategy [3]. Two patient groups were constructed
based on their ﬁnal diagnosis sustained on follow-up
(Fig. 1).
Statistical analysis
Data were analyzed with the Statistical Package of Social
Sciences (SPSS Inc., Chicago, IL). Continuous data was
expressed as mean (standard deviation) for normal vari-
ables and median (range) for non-normal variables. Nom-
inal variables were expressed as the percentage of patients
positive for this variable over the total number scored in the
patient category.
Data between CSS and non-CSS patients were compared
by using a v
2 test or Fisher’s exact test, as appropriate, for
nominal variables, or Student’s t test or Wilcoxon’s rank-
sum test, as appropriate, for continuous data. Relevant
clinical features for the diagnosis of CSS were selected by a
univariate analysis. Clinical features of CSS, signiﬁcant at
p\0.15 in univariate analysis and scored in C100 patients
were eligible for multivariate logistic regression analysis.
For these factors, sensitivity, speciﬁcity, positive predictive
value, and negative predictive value was calculated.
p\0.05 value was considered statistical signiﬁcant. Non-
signiﬁcant variables were removed one by one from the full
model, until the model signiﬁcantly deteriorated, based on
the -2log likelihood. With these results, a predictive model
wasconstructedandinteractionbetweenvariableswastested
if necessary. These data were expressed as odds ratio with
95% conﬁdence interval (CI).
Results
Patient characteristics
During the study period, 410 patients were referred for
analysis of suspected CSS. The ﬂow chart of the study is
presented in Fig. 1. A total of 270 patients with chronic
abdominal symptoms and stenosis of at least one splanchnic
artery were eligible for analysis; 109 patients had the ﬁnal
diagnosis CSS (72 with CSS and 37 with CACS), and 161
were diagnosed with CSD. Patient characteristics are out-
lined in Table 1.
CSS, CACS, and CSD
Overall clinical presentation of patients with CACS was
comparable to patients with atherosclerotic CSS. For the
CACS cohort, the duration of complaints was longer (18
vs. 7 months, p = 0.03), weight loss was less common in
the CACS patients (72% vs. 91%, p = 0.01), and more
patients with CACS experienced pain during stress (50%
vs. 27%, p = 0.02). For further analysis, patients with
CACS and atherosclerotic CSS were taken together and
compared with CSD patients.
In patients with CSS, mean age was 54 (range, 16–84)
years, and 33% was male. In the CSD, the mean age was 53
(range, 15–84) years, and 41% was male (not signiﬁcant).
Results from univariate analysis between CSS and CSD
patients are presented in Table 2. The mean duration of
symptoms was shorter in CSS vs. CSD (10.5 vs. 14.0
months, p = 0.02). Postprandial pain was signiﬁcantly
more often reported in CSS patients (87 vs. 72%, p =
0.007). Time between end of the meal and onset of the pain
was not statistically signiﬁcant between the two groups.
Diarrhea and weight loss were signiﬁcantly more often
reported in patients with CSS compared with CSD (diar-
rhea 35% vs. 22%, p = 0.02; weight loss 85% vs. 70%,
p = 0.006). The results of the univariate analysis of the
clinical features are presented in Table 3. Their individual
potential to distinguish CSS from CSD is low with the
highest accuracy for diarrhea (61%) and the lowest accu-
racy for postprandial pain and change in eating habits (both
49%).
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The main clinical features with p\0.15 in the univariate
analysis and scored in[100 patients were used for multi-
variate logistic regression analysis. Adapted eating pattern
(OR 3.1; 95% CI 1.08–8.88) and diarrhea (OR 2.6; 95% CI
1.31–5.3) were statistically signiﬁcant clinical features in
multivariate analysis. A prediction model was constructed
from four signiﬁcant of the clinical features in univariate
analysis. These included ‘‘adapted eating pattern,’’ ‘‘weight
loss,’’ ‘‘diarrhea,’’ and ‘‘postprandial pain.’’ This model
could be tested in the 164 patients in whom the presence of
absence of these factors was known (Table 4). The prob-
ability for CSS in absence of the four criteria was 13%
Fig. 1 Flowchart of study
protocol. CSS chronic
splanchnic syndrome, NOMI
nonobstructive mesenteric
ischemia, CACS celiac artery
compression syndrome, CSD
chronic splanchnic disease
Table 1 Characteristics of patients with ﬁnal diagnosis CACS, CSS and CSD
Patient characteristics
Total group (n = 270); 102 males;
median age, 53 (range 15–84) years
Atherosclerotic CSS
(n = 72)
CACS
(n = 37)
CSD
(n = 161)
Sex (male:female) 30:42* 6:31
# 66:95
Median age (yr) (range) 65 (33–84)
$* 34 (15–75)
# 52 (16–84)
Mean body mass index (kg/m
2) (SD) 22.5 (4.5) 21.8 (3.7)
# 23.5 (4.6)
Diabetes 14% 0%
# 11%
Hypertension 44%
$$** 3%
## 16%
Hypercholesterolemia 11% 6% 6%
Coronary artery disease 28%
$*0 %
# 14%
Peripheral artery disease 51%
$$** 0%
## 25%
Earlier episode of colonic ischemia 4% 3% 1%
Smoking 54%
$ 28%
# 48%
Family members with atherosclerosis 74%
$* 58% 57%
Median duration of follow-up (mo) (range) 10 (1–37) 15 (2–39) 8 (1–43)
Median duration of symptoms (mo) (range) 7.0 (0.2–120) 18 (1–252) 14 (0.1–408)
Patients without follow-up 6 0 122
CSS chronic splanchnic syndrome, CACS celiac artery compression syndrome, CSD chronic splanchnic disease
$ p\0.05 for atherosclerotic CSS vs. no CSS;
$$ p\0.001 for atherosclerotic CSS vs. CSD; * p\0.05 for atherosclerotic CSS vs. CACS;
** p\0.001 for atherosclerotic CSS vs. CACS;
# p\0.05 for CACS vs. CSD;
## p\0.001 for CACS vs. CSD
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in seven patients, of whom one had multivessel CSS. The
probability for CSS in presence of all four criteria was 60%
(number needed to treat, 1.7). This was present in six
patients in whom four actually had CSS. Two or three
clinical features were present in the medical history of 151
patients.
Discussion
The medical history of patients with splanchnic artery
stenosis may help to predict the presence of chronic gas-
trointestinal ischemia (chronic splanchnic syndrome or
CSS). In addition to the well-established ischemic com-
plaints of pain after meals and weight loss, we found
diarrhea and the presence of an adapted eating pattern as
signiﬁcant clinical features of CSS. In our study popula-
tion, the likelihood for CSS increased from 13% when none
of these four factors was present to 60% when all were
present. Therefore, even in patients with the most suspi-
cious clinical presentation of CSS, 40% of them where
actually not suffering from their splanchnic artery stenosis
(chronic splanchnic disease or CSD), and treatment would
be not indicated.
Postprandial pain and the presence of weight loss were
present in the majority of both CSS and CSD patients and
did not help in differentiation between CSS and CSD. BMI
and degree of weight loss was not statistically signiﬁcant
either. Probably this is all caused by selection bias because
for most referring physicians, postprandial pain and weight
loss trigger the suspicion of CSS. These are considered
typical for GI ischemia [5]. The two complaints that were
independent risk factors for the presence of CSS in this
study, diarrhea and an adapted eating pattern, are less well
established. Both factors have been described before in the
clinical presentation of CSS as atypical features, but have
not been appreciated as important factors [4].
Table 2 Major features from medical history notes and questionnaire of CSS patients versus CSD patients; results from the univariate analysis
Clinical feature Scored
b CSS (n = 109) CSD (n = 161) p value
Postprandial pain 228 87 % 71% 0.007
a
Median interval end of meal – onset of pain (min) (range) 106 15 (5–120) 15 (5–360) 0.84
Median duration of pain (hr) (range) 113 2.0 (0.3–96) 2.0 (2.0–72) 0.09
a
Weight loss 262 85% 70% 0.006
a
Median weight loss in kg/month (range) 194 1.8 (0.1–12) 1.9 (0.3–14.3) 0.85
Adapted eating pattern
c 168 90% 79% 0.07
a
Smaller portions 129 100% 90% 0.02
Pain after exercise 262 62% 67% 0.45
Pain with stress 257 35% 41% 0.34
Pain in relation with posture 211 64% 56% 0.23
Diarrhea 264 35% 22% 0.02
a
Total group (n = 270)
CSS chronic splanchnic syndrome; CSD chronic splanchnic disease
a Used for multivariate analysis;
b number of patients in which the clinical feature was described;
c smaller portions, change in meal composition
Table 3 Performance of signiﬁcant clinical features to diagnose
chronic splanchnic syndrome
Clinical
feature
Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Postprandial
pain
72 35 41 66 49
Weight loss 80 30 44 75 52
Change in
eating
habits
90 21 44 75 49
diarrhea 34 78 49 65 61
PPV positive predictive value, NPV negative predictive value
Table 4 Probability of chronic splanchnic syndrome in the study
population
Clinical features present
in medical history
Probability
of CSS (%)
NNT
(mean)
0 13 7.7
1 14–29 7.1–3.4 (5.3)
2 18–51 5.5–2.0 (3.8)
3 37–51 2.7–2.0 (2.4)
4 60 1.7
The clinical features were adapted eating pattern, diarrhea, post-
prandial pain, and weight loss
NNT numbers needed to treat
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classical risk factors (postprandial pain, weight loss) with
adapted eating pattern and diarrhea had a modest perfor-
mance in risk assessment of CSS. Furthermore, the per-
formance to safely exclude low-risk patients from
diagnostic workup was poor. In the absence of all four
complaints, there was still a 13% probability on the pres-
ence of CSS. If this patient group would not undergo the
diagnostic workup, this would lead to a minor reduction in
workload, but at the expense of missing important
pathology. The disappointing role of the medical history in
ischemia detection is in line with a recent paper by Sana
et al. who assessed the clinical features of CSS as well.
Their strongest predictors were ‘‘postprandial pain’’ and
‘‘weight loss per kg/month.’’ Their data support our con-
clusion that clinical features alone have a limited value to
correctly diagnose CSS [18].
The risk stratiﬁcation model, as described in Table 4,
may be used in daily clinical practice to estimate the risk
for CSS if the severity of splanchnic artery stenosis is taken
into consideration. Especially in patients with single vessel
involvement, a low pre-test probability might justify a wait
and see policy, because the prognosis on mortality is
excellent and the risk on acute bowel infarction is absent.
In multivessel disease, with a signiﬁcant chance of bowel
infarction and death, proper evaluation is indicated even in
absence of ischemic complaints [19, 20]. Further studies, in
nontertiary centres are needed to evaluate the utility of the
constructed risk model.
Because clinical history alone is insufﬁcient to dis-
criminate between CSS and CSD, other diagnostic tests are
needed. Both air tonometry and visible light spectroscopy
are methods to detect mucosal ischemia in the gastroin-
testinal tract. The technical principles of both techniques
have been extensively described elsewhere [2, 21]. Noord
et al. showed that both tests have almost similar accuracy
[21]. For tonometry, Otte et al. showed in a large patient
cohort that sensitivity and speciﬁcity for detection of
ischemia were 78% and 92%, respectively [11]. In a cohort
with 28 patients ultimately diagnosed with CSS, 57%
would have been missed with clinical history alone,
whereas the accuracy of tonometry was 80% [13].
This analysis was performed from a large data set to
identify factors in the clinical history that would help to
preselect patients who would need further analysis, and
hopefully eliminate individuals with a very low probability
on CSS. The results of this study indicate that clinical
history alone is clearly insufﬁcient and a test that accu-
rately demonstrates ischemia is needed.
This study has its methodological shortcomings. First,
patients were included that were referred to our specialized
working group. This has probably ﬁltered out patients with
less typical presentation for gastrointestinal ischemia.
Probably, most patients with splanchnic artery stenosis are
asymptomatic in daily life [22, 23]. Therefore, using the
same four criteria in a nontertiary center will probably lead
to even lower likelihoods for CSS. Second, the method of
data collection has its drawbacks. To avoid missing data,
we included both the notes of two highly experienced cli-
nicians, as well as a standard questionnaire. The medical
notes from the former contained more factors known to be
speciﬁc for CSS and less nonspeciﬁc issues. Both clinicians
only reported remarkable items in the medical history notes,
either positive or negative, with regard to CSS as diagnosis.
Parameters from the medical history notes could only be
scored as present or absent when speciﬁcally mentioned. If
it was not mentioned, it could not be ascertained with 100%
certainty whether that item had been discussed with the
patient. Therefore, it was scored as ‘‘missing.’’ This resulted
in a reliable dataset, at the expense of loss of information.
The data from the questionnaire were more complete on
these less-typical complaints but may have been subject to
interpretative problems.
In conclusion, in patients with splanchnic stenosis, four
parameters determine the likelihood of having gastroin-
testinal ischemia. These factors are postprandial pain,
weight loss, adapted eating pattern, and diarrhea. The
likelihood rose from 13% to 60% when none or all were
present. This is not sufﬁcient to make a decision about
which patient to treat. An accurate function test to dem-
onstrate ischemia is needed for an accurate diagnosis of
chronic gastrointestinal ischemia.
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Appendix
Questionnaire
• Postprandial pain
• After a meal, I experience
1. No pain
2. Pain, but it does not interfere with daily life
3. Pain, with small impairment on daily life
4. Pain, with severe impairment on daily life
5. Pain, with total impairment on daily life
• Pain with exertion
• After physical exercise, I experience
1. No pain
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1232. Pain, but it does not interfere with daily life
3. Pain, with small impairment on daily life
4. Pain, with severe impairment on daily life
5. Pain, with total impairment on daily life
• Pain with stress
• During mental stress, I experience
1. No pain
2. Pain, but it does not interfere with daily life
3. Pain, with small impairment on daily life
4. Pain, with severe impairment on daily life
5. Pain, with total impairment on daily life
• Relationship with posture
• Do you experience more pain in a certain posture?
Yes or no
• Stools
• How many times a day do you defecate?
• What is the consistency?
1. Separate hard lumps, like nuts (hard to pass)
2. Sausage-shaped, but lumpy
3. Like peanut butter a sausage or snake, smooth
and soft
4. Watery, no solid pieces. Entirely liquid
• Weight loss
• Did you lose weight recently?
Yes or no
• Degree of weight loss (kg/month)
• I lost……kilograms of weight during the last……-
weeks / months / years
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